CNBC February 3, 2025
Annika Kim Constantino

Key Points

– President Donald Trump’s steep tariffs on Canada, Mexico and China could worsen exist­ing drug short­ages in the U.S. and raise health-care costs for patients, some drug trade groups warn.

– They also said the import taxes could strain cash-strapped generic drugmakers and distributors.

– Trump on Saturday announced he would impose a 25% tariff on nearly all goods shipped from Canada and Mexico and a 10% charge on imports from China.

President Donald Trump‘s steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug shortages in the U.S., raise health-care costs for patients and threaten cash-strapped generic drugmakers, some drug trade groups warn.

Trump on Saturday announced he would impose a 25% tariff on nearly...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Another Reprieve? Proposed Budget Bill Includes Telehealth, HaH Extensions
House expected to consider CR to fund government through Sept. 30, extend key health care provisions
Federal research cuts could worsen infectious disease toll worldwide, expert warns
Trump administration ditches Biden-era ACA flexibilities
A Policy Shift Impacting Medical Coding in Healthcare

Share This Article